证券代码：300190 证券简称：维尔利 3、公司在天然气业务行业的市场开发策略？ 编号：2026-001 | 投资者关系活 | 分析师会议 □特定对象调研 □ | | --- | --- | | 动类别 □ | 媒体采访 □ 业绩说明会 | | □ | 新闻发布会 □ 路演活动 | | | □现场参观 √ 其他 （电话会议） | | 参与单位名称 | 融通基金 姚垚 汇丰晋信 韦钰 汇丰晋信 王家怡 国泰基金 | | 及人员姓名 | 谢泓材 光大宝德信 董旭 民生加银 汤思懿 华宝基金 居帧 | | | 紫金信托 魏宁伟 博时基金 陈牧涵 博时基金 金欣欣 申万证 | | | 券 莫龙庭 兴业证券 胡冰清 交银施罗德基金 庄彤芸 工银瑞 | | | 信基金 袁路欣 国中长城资产 刘志强 交银施罗德 刘鹏 安华 | | | 农业保险 张放 东方财富 周喆 中信证券 任丹 中银证券 徐 | | | 中良 东吴证券 袁理 陈孜文 田源 高熵基金 钟诚 华泰证券 | | | 王玮嘉 李雅琳 银华基金 杨丹 天弘基金 杜田野 华夏基金 | | | 艾邦妮 睿郡 丁晨霞 易方达 吴奇 银华基金 张玲 瑞众保险 | | ...

Core Viewpoint - The company is advancing its capital increase through a private placement and divesting inefficient assets, while its Sustainable Aviation Fuel (SAF) business has achieved scaled production and received export quotas [1]. Group 1: Capital Increase - The company is progressing with a private placement of shares for 2024, primarily aimed at upgrading product quality for the Shandong Sanju Bioenergy project and supplementing working capital [2]. - The resolution from the relevant shareholders' meeting has been extended until December 25, 2026, with future attention needed on regulatory approvals and implementation progress [2]. Group 2: Company Status - The company is working on the disposal of its subsidiary Sichuan Xinda to further focus on its core bioenergy business, with completion expected by the second quarter of 2026 [3]. Group 3: Business Operations - The subsidiary Shandong Sanju plans to conduct annual maintenance and replacement of materials in 2026, which has been incorporated into the overall production plan and is not expected to significantly impact annual capacity [4]. Group 4: Business Progress - The company's SAF products achieved stable production and sales at scale by October 2025 and have received export whitelist status and quotas, with long-term contracts with European clients being executed as planned [5]. Group 5: Corporate Structure and Governance - A board meeting is scheduled for February 6, 2026, to review internal governance documents such as the "Implementation Measures for Accountability of Violations in Business Investments," indicating potential operational strategy optimization under the new management [6].

Core Viewpoint - Watson Bio (300142.SZ) has announced the establishment of the Yunnan Chuangwo Biological Industry Investment Fund in collaboration with several partners, aiming for a target size of 1 billion yuan, with the company contributing 450 million yuan as a limited partner [1] Group 1: Investment Fund Details - The fund's target size is set at 1 billion yuan [1] - Watson Bio will invest 450 million yuan of its own funds as a limited partner [1] - The fund will focus on various investment areas including synthetic biology, life and health, biological agriculture, bioenergy, biomaterials, technology platform enterprises, and high-throughput equipment [1] Group 2: Investment Areas - Investment areas include synthetic biology such as enzyme preparations, amino acids, and probiotics [1] - Life and health investments will cover plant extracts, recombinant collagen, sweeteners, and protein drugs [1] - Biological agriculture will focus on feed protein, micro-ecological preparations, animal vaccines, and biological nitrogen fixation [1] - Bioenergy investments will include bioethanol and biodiesel [1] - Biomaterials will focus on PLA, PHA, and PDO [1] - The fund will also target technology platform enterprises like strain development and AI protein design [1] - High-throughput equipment investments will include microfluidic devices and gene sequencing equipment [1]

Group 1 - Watson Bio announced the establishment of the Yunnan Chuangwo Biological Industry Investment Fund in collaboration with several partners [1] - The target scale of the fund is 1 billion yuan, with Watson Bio contributing 450 million yuan as a limited partner [1] - The fund will primarily invest in the synthetic biology manufacturing industry, including sectors such as synthetic biology, health and wellness, bio-agriculture, bio-energy, bio-materials, and technology platform enterprises [1]

Summary of Key Points from the Conference Call Company Overview - The company discussed is 卓越新能 (Zhuoyue New Energy), which operates in the chemical industry, specifically focusing on biofuels and related products. Financial Performance - In 2025, the company reported a revenue of 2.942 billion yuan, representing a year-on-year decrease of 17.43% [1] - The net profit attributable to shareholders was 170 million yuan, showing a year-on-year increase of 14.16% [1] - The non-recurring net profit reached 190 million yuan, marking a significant year-on-year growth of 40.95% [1][2] Strategic Adjustments - The company adjusted its operational strategy, which contributed to an increase in overall product gross margins [2] - The production line for natural fatty alcohol has been launched, which is expected to enhance profitability [2] Future Developments - The company has a domestic capacity of 500,000 tons/year for ester-based biodiesel and plans to launch a first-line production capacity of 100,000 tons/year for HVO/SAF in 2026 [2] - Construction of a second line for hydrocarbon production is set to commence [2] - The company is also advancing its overseas capacity projects and building a supply chain system [3]

Group 1: Business Overview - The company operates in three main business segments: - Fuel ethanol business accounts for approximately 44% of revenue, with a production capacity of 1.3 million tons and a market share of 32%-40% in a domestic market of about 3 million tons per year [1][2] - Food raw materials business contributes around 20%-30% of revenue, focusing on customized sweetener solutions for leading food and beverage companies [2][3] - Biobased new materials business is a strategic emerging segment expected to start production in Q1 2026, leveraging existing corn deep processing capacity [3][4] Group 2: Competitive Landscape - Fuel ethanol is categorized as biomass energy, with no direct competition from coal-based ethanol due to regulatory restrictions [3][4] - Long-term demand for fuel ethanol remains stable, driven by the coexistence of fuel and new energy vehicles and regulatory requirements for gasoline quality [4][5] - The company aims to maintain its market position by building a comprehensive cost advantage through technology upgrades, diversified raw material sourcing, and optimized internal management [5][6] Group 3: Regional Strategies - In Northeast China, the company focuses on cost reduction and efficiency improvements through personnel optimization and major technological upgrades [6][7] - The company is adapting its competitive strategy in the starch and MSG sectors by shifting focus from low-value products to high-margin offerings [7][8] Group 4: Innovation and Future Prospects - The company has a three-step strategy for its core health sweetener product, allulose, with plans for market expansion and collaboration with leading food and beverage companies [8][9] - The company anticipates that high-value products like flavored syrups will see increased revenue share as market demand grows [9] - The progress of the lactide project has been delayed due to site relocation and necessary adjustments, but the long-term outlook remains positive [9] Group 5: Raw Material Management - The company employs risk management strategies, including hedging, to manage procurement costs and mitigate price volatility risks, particularly for corn [9]

Group 1: Business Overview - The company operates in three main business segments: - Fuel ethanol business accounts for approximately 44% of revenue, with a production capacity of 1.3 million tons and a market share of 32%-40% in a domestic market of about 3 million tons [1][2] - Food raw materials business contributes around 20%-30% of revenue, focusing on customized sweetener solutions for leading food and beverage companies [2] - Bio-based new materials business is a strategic emerging segment expected to start production in Q1 2026, leveraging existing corn deep processing capacity [2][3] Group 2: Competitive Landscape - Fuel ethanol is categorized as a biomass energy source, with no direct competition from coal-based ethanol due to regulatory restrictions [3] - Long-term demand for fuel ethanol remains stable, driven by the coexistence of fuel and new energy vehicles and stringent gasoline quality standards [3][4] - The company aims to maintain its market position by building a comprehensive cost advantage through technology upgrades, diversified raw material sourcing, and optimized internal management [4] Group 3: Regional Strategies - In Northeast China, the company focuses on cost reduction and efficiency improvements by optimizing personnel and implementing major technological upgrades [5] - The company is actively responding to competition from private enterprises in the starch and MSG sectors by shifting focus to high-value products and differentiating its offerings [6] Group 4: Innovation and Product Development - The company has a three-step strategy for the development of allulose, a key health sweetener, with plans for market launch in Q1 2026 [7] - Allulose is expected to have a higher gross margin than traditional glucose syrup, with optimistic short-term performance depending on market demand [7] - High-value products like flavored syrups are in the market incubation phase, with significant growth potential as consumer scenarios expand [8] Group 5: Project Management and Future Outlook - The company has relocated its lactide project to Anhui, which has caused delays due to necessary design optimizations and equipment adjustments [9] - The long-term outlook for the lactide business is positive, with plans to ensure stable operation of the initial 30,000 tons capacity and potential expansion into downstream polylactic acid markets [9] - The company employs risk management strategies, including hedging, to manage corn price fluctuations and secure profit margins [9]

Core Viewpoint - Company is focusing on the development of bioenergy and catalytic purification materials, with a core emphasis on high-value utilization of waste oils, particularly in the production of hydrocarbon-based biodiesel (HVO) and sustainable aviation fuel (SAF) [2][3] Group 1: Company Performance and Strategy - As of January 30, 2026, the company's stock closed at 4.75 yuan, down 6.86%, with a turnover rate of 4.7% and a trading volume of 1.0951 million shares, amounting to a transaction value of 528 million yuan [1] - The company has begun large-scale stable production and sales of SAF products since October 2025, indicating a strategic move towards expanding its bioenergy segment [2] - The company plans to accelerate the divestment of low-efficiency assets and focus on strengthening its core bioenergy business while maintaining a meticulous approach in the catalytic purification sector [3] Group 2: Production and Capacity - The company’s subsidiary, Shandong Sanju Biodiesel (HVO), is currently operating at a high production load, indicating strong operational performance [2][3] - A planned maintenance and catalyst replacement for the Shandong aviation fuel project in 2026 is part of the annual production schedule and is not expected to impact overall production capacity for the year [4] Group 3: Financial Outlook and Market Position - The company is actively working on the disposal of its subsidiary Sichuan Xinda, which is expected to incur losses in 2025, as part of its strategy to focus on the bioenergy main business [3] - Recent trading data shows a net outflow of 85.0646 million yuan from major funds, while retail and speculative funds experienced net inflows of 45.593 million yuan and 39.4716 million yuan, respectively, reflecting mixed market sentiment [5]

Core Viewpoint - Company expects a net loss of 450 million to 640 million yuan for the year 2025, with a projected net profit excluding non-recurring losses ranging from -770 million to -540 million yuan [1] Group 1: Financial Performance - The company's bioenergy segment revenue increased by approximately 580 million yuan, representing a year-on-year growth of about 46% due to rising product prices and capacity release [1] - The gross profit for the bioenergy segment increased by approximately 270 million yuan, leading to a turnaround from loss to profit, significantly enhancing operational efficiency [1] - The company anticipates asset impairment losses of around 250 million yuan for the reporting period, based on cautious principles and evaluations of inventory and fixed assets [1] Group 2: Market Environment - The global green energy policy environment continues to improve, with the EU and UK implementing regular biojet fuel (SAF) blending policies, and major economies like China, Japan, and South Korea clarifying their green transition paths [1] - The company successfully obtained approval for SAF product export in October 2025, marking a strategic breakthrough in its development [1] Group 3: Challenges in Other Segments - The company's environmental materials and chemical products business faced challenges due to cyclical adjustments in the petroleum refining and coal chemical industries, leading to a pressured market environment for catalyst and purification products [1] - The rapid expansion of capacity in the LNG and neopentyl glycol industries outpaced demand growth, exacerbating competition within the industry [1]

Group 1 - The core viewpoint of the article is that Zhuoyue New Energy is advancing its international development strategy through the establishment of a bioenergy project in Thailand, which is a significant step for the company [1][3]. - The bioenergy project will utilize local resources such as kitchen waste oil and palm acid oil to produce 300,000 tons of biodiesel and 100,000 tons of HVO (hydrotreated vegetable oil) / SAF (sustainable aviation fuel) annually [3]. - The total investment for the project is 700 million yuan, which will be implemented in two phases, with the first phase focusing on the biodiesel production line [3]. Group 2 - The products from the bioenergy project will primarily supply markets in Europe, North America, and Southeast Asia, targeting aviation, maritime, and land transportation sectors [3].